North American Inflammatory Bowel Disease (IBD) Market Size, Industry Share, Growth & Forecast To 2025

1. Orion Market Research North American Inflammatory Bowel Disease (IBD) Market, Size, Share, Analysis Report & Forecast to 2025 Market: Request https://www.omrglobal.com/request-sample/north-american-ibd-inflammatory-bowel- disease-market a Free Sample of our Report on North American IBD Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

2. The North American IBD market is estimated to grow significantly at a CAGR of around 4.8% during the forecast period. Rising prevalence and incidence of IBD across the region is the major driving factor for the market. Moreover, an increasing number of cigarette-smokers in the US and significant funding in the IBD field in Canada is further estimated to boost the market growth of the region. Furthermore, well-developed healthcare expenditure coupled with increased per capita healthcare expenditure across the region will support the market growth over the forecast period. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/north-american-ibd- inflammatory-bowel-disease-market North American IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. North American IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery. A Full Report of North American Inflammatory Bowel Disease (IBD) Market is Available at: https://www.omrglobal.com/industry-reports/north-american-ibd-inflammatory-bowel- disease-market The companies which are contributing to the growth of the North American IBD market include Abbott Laboratories, AbbVie Inc., Accesa Labs, Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Laboratory Corporation of America Holdings, Pfizer Inc., and others. Market Segmentation North American IBD Market by Disease Type

3. •Ulcerative Colitis •Crohn’s Disease North American IBD Market by Diagnostics •Blood and Stool Tests •Endoscopies, •Ultrasound •X-Ray North American IBD Market by Therapeutics •Surgery •Anti- Inflammatory Drug Administration •Steroids •Immunosuppressant •Biological Drugs •Amino salicylates •Others Regional Analysis •United States •Canada For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-ibd-inflammatory-bowel- disease-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

4. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404